These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24164039)

  • 1. [An assay for anti-factor Xa activity of low molecular weight heparins by high performance liquid size exclusion chromatography].
    Zhang Q; Kang J
    Se Pu; 2013 Jul; 31(7):684-90. PubMed ID: 24164039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of the anticoagulant activity of low molecular weight heparins by micellar electrokinetic chromatography combined with on-column enzymatic reaction].
    Zhang M; Kang J
    Se Pu; 2020 Oct; 38(10):1243-1248. PubMed ID: 34213123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays.
    Harris LF; O'Brien A; Castro-López V; O'Donnell JS; Killard AJ
    Thromb Res; 2011 Dec; 128(6):e166-70. PubMed ID: 21872908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of anticoagulant activity for low molecular-weight heparin by chromogenic substrate. Measurement of factor Xa and thrombin activities].
    Ishimitsu S; Sugiyama T; Itoh M; Natsuga T; Komatsu H; Okada S
    Yakugaku Zasshi; 1994 Aug; 114(8):611-7. PubMed ID: 7932105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.
    Castro-López V; Harris LF; O'Donnell JS; Killard AJ
    Anal Bioanal Chem; 2011 Jan; 399(2):691-700. PubMed ID: 20972772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas.
    Harris LF; Castro-López V; Jenkins PV; O'Donnell JS; Killard AJ
    Thromb Res; 2011 Dec; 128(6):e125-9. PubMed ID: 21824646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.
    Harris LF; Castro-López V; Hammadi N; O'Donnell JS; Killard AJ
    Talanta; 2010 Jun; 81(4-5):1725-30. PubMed ID: 20441964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new chronometric assay to determine plasma antifactor Xa activity which is insensitive to the antithrombin activity of low molecular weight heparins.
    Dignac M; Gabaig AM; Cambus JP; Boneu B
    Nouv Rev Fr Hematol (1978); 1994; 35(6):545-9. PubMed ID: 8152901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels.
    Schaefer B; Hausfeld A; Martin M; Steele P; Martin J; Reher SR; Lane A; Luchtman-Jones L
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28654. PubMed ID: 32841498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the pharmacokinetic parameters of low molecular weight heparins predictive of their clinical efficacy?
    Andrassy K; Eschenfelder V
    Thromb Res; 1996; 81(2 Suppl):S29-38. PubMed ID: 8822125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
    Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
    Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of the chronometric assays to determine plasma antifactor Xa activity during low molecular weight heparin therapy.
    Boneu B; Faruel-Bille V; Pierrejean D; Gabaig AM
    Nouv Rev Fr Hematol (1978); 1991; 33(4):287-91. PubMed ID: 1664095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
    Dempfle CE; Zharkowa U; Elmas E; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Thromb Haemost; 2009 Nov; 102(5):1001-6. PubMed ID: 19888540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity.
    Achour O; Bridiau N; Godhbani A; Le Joubioux F; Bordenave Juchereau S; Sannier F; Piot JM; Fruitier Arnaudin I; Maugard T
    Carbohydr Polym; 2013 Sep; 97(2):684-9. PubMed ID: 23911501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant effects of low-molecular-weight heparins in healthy cats.
    Alwood AJ; Downend AB; Brooks MB; Slensky KA; Fox JA; Simpson SA; Waddell LS; Baumgardner JE; Otto CM
    J Vet Intern Med; 2007; 21(3):378-87. PubMed ID: 17552440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of heparins in antithrombin-deficient patients.
    Croles FN; Lukens MV; Mulder R; de Maat MPM; Mulder AB; Meijer K
    Thromb Res; 2019 Mar; 175():8-12. PubMed ID: 30660948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.
    Brieger D; Dawes J
    Thromb Haemost; 1997 Feb; 77(2):317-22. PubMed ID: 9157589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
    Lin P; Sinha U; Betz A
    Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.
    Linhardt RJ; Loganathan D; al-Hakim A; Wang HM; Walenga JM; Hoppensteadt D; Fareed J
    J Med Chem; 1990 Jun; 33(6):1639-45. PubMed ID: 2160537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.